Scholarlink

Purpose <p>Vitamin D (VD) deficiency significantly contributes to intervertebral disc degeneration (IDD), a common cause of low back pain, yet the underlying mechanisms remain unclear. This study investigates how VD deficiency exacerbates IDD and identifies potential therapeutic targets.</p> Methods <p>We used real-time quantitative PCR, immunoblots, immunoprecipitation, liquid chromatography with tandem mass spectrometry analysis, co-immunoprecipitation, and chromatin immunoprecipitation to study gene and protein expressions, protein complex assembly, and transcriptional complex binding. Degeneration of IVDs was assessed via hematoxylin and eosin staining.</p> Results <p>Eight members of <i>ADAMTSs</i> (A disintegrin and metalloproteinase with thrombospondin motifs) are enriched in lumbar discs of both VD-deficient and VD receptor (VDR)-knockout (VDR<sup>−/−</sup>) mice. Sufficient VD suppresses <i>ADAMTS</i> genes through a complex formed by nuclear receptor corepressor 2 (NCoR2) and signal transducer and activator of transcription 6 (STAT6). VD deficiency activates p38 kinase, leading to NCoR2 phosphorylation and subsequent degradation by a Cullin 4-RING (CRL4) E3 ligase, impairing NCoR2’s transrepression function and upregulating <i>ADAMTS</i> genes, accelerating extracellular matrix (ECM) degradation in discs. This mechanism is replicated in VDR-deficient cells. In vitro treatments with p38 inhibitor (BIRB-796) and CRL4 inhibitor (KH-4-43) reduce <i>ADAMTS</i> expression, and in vivo application of these inhibitors improves disc integrity in VD-deficient mice.</p> Conclusion <p>Our findings highlight NCoR2 degradation, mediated by p38 kinase and CRL4 E3 ligase, as crucial in VD deficiency-induced IDD. Targeting this pathway offers promising therapeutic potential to mitigate IDD progression in individuals with VD deficiency or VDR abnormalities.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Vitamin D deficiency promotes intervertebral disc degeneration via p38/NCoR2-mediated extracellular matrix degradation

  • 期刊论文

  • 发表日期：

    2025年4月24日

查看全文
  • Xingguo Li,
  • Bing Wang,
  • Xuenan Wang,
  • Chao Chen,
  • Enyu Zhan,
  • Zhengpin Lv,
  • Qicong He,
  • Yaoquan Hu,
  • Fan Zhang

摘要

Purpose

Vitamin D (VD) deficiency significantly contributes to intervertebral disc degeneration (IDD), a common cause of low back pain, yet the underlying mechanisms remain unclear. This study investigates how VD deficiency exacerbates IDD and identifies potential therapeutic targets.

Methods

We used real-time quantitative PCR, immunoblots, immunoprecipitation, liquid chromatography with tandem mass spectrometry analysis, co-immunoprecipitation, and chromatin immunoprecipitation to study gene and protein expressions, protein complex assembly, and transcriptional complex binding. Degeneration of IVDs was assessed via hematoxylin and eosin staining.

Results

Eight members of ADAMTSs (A disintegrin and metalloproteinase with thrombospondin motifs) are enriched in lumbar discs of both VD-deficient and VD receptor (VDR)-knockout (VDR−/−) mice. Sufficient VD suppresses ADAMTS genes through a complex formed by nuclear receptor corepressor 2 (NCoR2) and signal transducer and activator of transcription 6 (STAT6). VD deficiency activates p38 kinase, leading to NCoR2 phosphorylation and subsequent degradation by a Cullin 4-RING (CRL4) E3 ligase, impairing NCoR2’s transrepression function and upregulating ADAMTS genes, accelerating extracellular matrix (ECM) degradation in discs. This mechanism is replicated in VDR-deficient cells. In vitro treatments with p38 inhibitor (BIRB-796) and CRL4 inhibitor (KH-4-43) reduce ADAMTS expression, and in vivo application of these inhibitors improves disc integrity in VD-deficient mice.

Conclusion

Our findings highlight NCoR2 degradation, mediated by p38 kinase and CRL4 E3 ligase, as crucial in VD deficiency-induced IDD. Targeting this pathway offers promising therapeutic potential to mitigate IDD progression in individuals with VD deficiency or VDR abnormalities.